Persistent aplasia after chemotherapy for acute myeloid leukaemia treated with stem cell transplantation from a matched unrelated donor after dose-reduced conditioning

Br J Haematol. 2002 Aug;118(2):442-4. doi: 10.1046/j.1365-2141.2002.03742.x.

Abstract

Persistent aplasia is a rare complication with poor prognosis after intensive chemotherapy for acute leukaemia. A 59-year-old man with acute myeloid leukaemia (AML), was treated after 186 d of chemotherapy-induced persistent aplasia with an allogeneic peripheral blood stem cell transplantation (PBSCT) from a matched unrelated donor (MUD) after dose-reduced conditioning. The patient remains in complete haematological remission more than 8.5 months after haematological recovery. We believe that this is the first reported case of treatment for chemotherapy-induced persistent aplasia with MUD-PBSCT after dose-reduced conditioning, a procedure that can be successfully performed even in elderly patients.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Anemia / chemically induced*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukemia, Myeloid / drug therapy
  • Leukemia, Myeloid / therapy*
  • Male
  • Middle Aged
  • Transplantation Conditioning
  • Transplantation, Homologous